16 August 2024 -- AstraZeneca’s Imfinzi (durvalumab) in combination with chemotherapy has been approved in the US for the treatment of adult...
Vous n'êtes pas connecté
The decision to treat patients with stage II medlinkcolon cancer/medlink using adjuvant chemotherapy remains controversial, creating an urgent need
16 August 2024 -- AstraZeneca’s Imfinzi (durvalumab) in combination with chemotherapy has been approved in the US for the treatment of adult...
A cancer diagnosis can be scary. Some cancers can be cured if caught early. Treatments like surgery, radiation, and chemotherapy can destroy many...
Patients with liver cancer who received immune checkpoint inhibitors (ICIs) before surgery – including those who would not have been eligible for...
The majority of cancer patients involved in a landmark Perth clinical trial remain in remission years later after a breakthrough treatment that...
medlinkImmunotherapy/medlink has significantly extended survival for advanced lung cancer patients. A new study published in iCANCER/i reveals
FRIDAY, Aug. 9, 2024 -- Radiation therapy following surgery can keep breast cancer from returning for up to 10 years, a new study claims. The study...
Corewell Health research suggests an MRI scan can help predict whether patients with intermediate-risk prostate cancer (cancer confined to the entire...
Advanced MRI scans and blood biomarkers may identify patients with concussion at risk for long-term symptoms, improving prognosis and follow-up...
Vorasidenib has been approved by the U.S. Food and Drug Administration (FDA) for patients with Grade 2 gliomas with IDH1 or IDH2 mutations. Based...
A new study from the University of Michigan Health Rogel Cancer Center, USA, finds that giving a fatty acid inhibitor alongside chemotherapy could...